osimertinib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (2)
Unknown (1)

Interventional (2)
Observational (1)

M.D. Anderson Cancer Center (1)
Shanghai JMT-Bio Inc. (1)
Universitaire Ziekenhuizen Leuven (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadcancer

I am/have/hadnon-small cell lung cancer

I am/have/hadmeasurable disease

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadmetastasis

I am/have/hadneutrophil count

I am/have/hadtyrosine

I am/have/hadliver metastasis

I am/have/hadcarcinoma

I am/have/hadrecurrent non-small cell lung cancer

I am/have/hadstage ivb lung cancer ajcc v8

I am/have/hadstage iv lung cancer

I am/have/hadstage iva lung cancer ajcc v8

I am/have/hadsolid tumors

I am/have/hadstage iv lung cancer ajcc v8

I am/have/hadlung carcinoma

I am/have/hadperiodic abstinence

I am/have/hadstereotactic body radiation therapy

I am/have/hadstage iiib lung cancer ajcc v8

added new label for I am/have/had

I am looking for

I am looking forosimertinib

I am looking forgrowth factor

I am looking fortyrosine

I am looking foralisertib

I am looking forglycosylated hemoglobin

I am looking forkinase inhibitor

I am looking forsapanisertib

I am looking forhba1c

I am looking forblockade

I am looking forhemoglobin a1c

I am looking fortotal bilirubin

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

This study is a Phase Ib, open label, multi-center study of to evaluate the safety and efficacy of JMT101 combined with EGFR-TKIs (Afatinib or Osimertinib) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations.

0 views
16 Feb, 2024
2 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Osimertinib With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

This phase Ib trial studies the side effects and best dose of alisertib or sapanisertib, in combination with osimertinib, in treating patients with EGFR mutated stage IIIB or IV non-small cell lung cancer that remains despite treatment with osimertinib (osimertinib resistant).

EGFR

carcinoma

serum glucose

absolute neutrophil count

lung cancer

0 views
16 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Recruiting

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

To determine whether in patients with EGFR mutated advanced NSCLC and osimertinib as first-line treatment, the (repeated) use of LAT to 3 OP lesions and continuation of first-line osimertinib, improves the median progression-free survival by more than 3 months (i.e.

0 views
16 Feb, 2024
1 location